Back to search
QT Prolongation
Clinical trial pipeline · Data from ClinicalTrials.gov
See which QT Prolongation trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which QT Prolongation trials you may qualify forThe goal of this observational study is to develop a registry of Brazilian patients with hereditary cardiovascular diseases, combining clinical and genomic data…
The goal of this prospective population-based study is to evaluate the new disease description and management guidelines for breath-holding spells in children (…
An important aspect of successful genomic medicine implementation is developing effective approaches for screening at-risk family members after probands are ide…
The goal of this clinical trial is to learn whether the study drug THRV-1268 can safely and effectively shorten the QT interval in people diagnosed with Long QT…
Electrocardiogram (ECG) Q-T prolongation is a cardiac electrophysiological disorder associated with the occurrence of arrhythmias potentially fatal. Several psy…
Each year world-wide, 2.5 million fetuses die unexpectedly in the last half of pregnancy, 25,000 in the United States, making fetal demise ten-times more common…
The aim of this clinical study is to determine which type of anesthesia has the least effect on the electrical activity of the heart in pregnant women undergoin…
GM508 CultActive is a bicarbonate buffered reagent and ready-to-use designed to investigate oocytes of patients with failed fertilization after previous Intracy…
This research will determine if: 1) Oral progesterone attenuates drug-induced QT interval, J-Tpeak and Tpeak-Tend lengthening in postmenopausal women 50 years o…